These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12839680)

  • 21. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
    Bártová E; Harnicarová A; Pacherník J; Kozubek S
    Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
    Li J; Xue L; Hao H; Han Y; Yang J; Luo J
    Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.
    Riordan FA; Bravery CA; Mengubas K; Ray N; Borthwick NJ; Akbar AN; Hart SM; Hoffbrand AV; Mehta AB; Wickremasinghe RG
    Oncogene; 1998 Mar; 16(12):1533-42. PubMed ID: 9569020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
    Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH
    Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL.
    Wang T; Wen T; Li H; Han B; Hao S; Wang C; Ma Q; Meng J; Liu J; Xu H
    Int J Nanomedicine; 2019; 14():5581-5594. PubMed ID: 31413564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.
    Li QF; Huang WR; Duan HF; Wang H; Wu CT; Wang LS
    Oncogene; 2007 Dec; 26(57):7904-8. PubMed ID: 17599053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorbitol-induced apoptosis of human leukemia is mediated by caspase activation and cytochrome c release.
    Marfè G; Morgante E; Di Stefano C; Di Renzo L; De Martino L; Iovane G; Russo MA; Sinibaldi-Salimei P
    Arch Toxicol; 2008 Jun; 82(6):371-7. PubMed ID: 18046541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of bcl-x(L) in K562 cells and its role in the low sensitivity of K562 to realgar-induced apoptosis.
    Zhang J; Wang JC; Han YH; Wang LF; Ji SP; Liu SX; Liu XP; Yao LB
    Acta Haematol; 2005; 113(4):247-54. PubMed ID: 15983431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells.
    Rakshit S; Mandal L; Pal BC; Bagchi J; Biswas N; Chaudhuri J; Chowdhury AA; Manna A; Chaudhuri U; Konar A; Mukherjee T; Jaisankar P; Bandyopadhyay S
    Biochem Pharmacol; 2010 Dec; 80(11):1662-75. PubMed ID: 20832390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective leukemia cell death by activation of the double-stranded RNA-dependent protein kinase PKR.
    Li YJ; Zeng JM; Huang SF; Wang XZ; Zhao SQ; Bai WJ; Cao WX; Huang ZG; Feng WL
    Int J Mol Med; 2011 Aug; 28(2):215-22. PubMed ID: 21468538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha].
    Li XM; Chen HC; Liu XF; Wu YH; Cao YF
    Ai Zheng; 2003 Oct; 22(10):1047-52. PubMed ID: 14558948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
    Xu Y; Voelter-Mahlknecht S; Mahlknecht U
    Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181.
    Gong J; Zheng S; Zhang L; Wang Y; Meng J
    Med Sci Monit; 2017 Jan; 23():144-150. PubMed ID: 28072759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
    Chun-Guang W; Jun-Qing Y; Bei-Zhong L; Dan-Ting J; Chong W; Liang Z; Dan Z; Yan W
    Eur J Pharmacol; 2010 Feb; 627(1-3):33-41. PubMed ID: 19857484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Apoptosis effects of drug sensitivity leukemia cells induced by nano-realgar].
    Wang YS; Zhou ST; Wei HL
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2202-5. PubMed ID: 24079254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.